A
joint marketing campaign has been launched for SynterAct, a probiotic
supplement consisting of 3P biotics developed for different age groups from
babies to seniors, and DeRAMA.
Ofmom
Korea, the company that launched SynterAct, and DeRAMA Global, an operator of
postpartum cancer centers, have been releasing a variety of baby food products
and supplies, functional health products, and other related products based on
the data and knowhow of, which has been developing various
products in partnership with children’s hospitals and doctors around the world.
After
launching Centre Ofmom Beijing in 2016, the two companies have expanded its
global network, spreading Korea’s postpartum care practices in Bangkok, Los
Angeles, and other locations around the world. The safe and effective health
supplement products of Ofmom Korea and the outcomes of research and
collaborations with domestic and overseas medical institutions have been
incorporated into prenatal care and postpartum practices through DeRAMA
Global’s network.
SynterAct
is a premium probiotic product line for improving gut health with products
targeting specific age groups and sexes, such as babies, seniors, and women.
Only
the strains that have been proven effective through studies and patents are
combined with prebiotics (dietary fiber), a source of food for gut microbiota,
into a 3P biotics. The formula promotes proliferation of beneficial bacteria
and minimizes side effects from excessive consumption of prebiotics, such as
indigestion or abdominal distention.
In
addition to the 3P biotics, which are pro-, pre- and post-biotics, the product
contains essential nutrients for the target age group or sex so that it can
promote general health, in addition to gut health.
A
representative of Ofmom Korea said, “This is meaningful in that mothers and
their babies can try out our products at DeRAMA, one of the best postpartum
care centers in Korea providing total care services from prenatal care to
postpartum examinations. [...] We plan on coming up with diverse collaborations
beyond our strategic partnership and provide opportunities for consumers to
experience the benefits of SynterAct, which is safe and of high quality.”
Source:
Jose Ilbo